Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Añadir filtros








Intervalo de año
1.
West China Journal of Stomatology ; (6): 599-603, 2023.
Artículo en Inglés | WPRIM | ID: wpr-1007944

RESUMEN

Stevens-Johnson syndrome (SJS), also known as the multifactorial erythematous drug eruption, is a class of adverse reactions of the skin and mucous membranes primarily caused by drug allergy often involving the oral cavity, eyes, and external genital mucosa, generally accompanied by fever, and can be life-threatening in severe cases. In February 2022, the Department of Stomatology, the First Affiliated Hospital of Zhengzhou University admitted a patient with huge inflammatory hyperplasia of bilateral lingual margins secondary to SJS. Upon admission, no other obvious symptoms were observed except for tongue hyperplasia. The patient suffered from a severe adverse drug reaction caused by acetaminophen 2 months ago and was complicated by liver dysfunction and pulmonary infection. After 1 month of treatment and rehabilitation, he developed a secondary tongue mass and was subsequently admitted to Dept. of Oral and Maxillofacial Surgery Ward 2, the First Affiliated Hospital of Zhengzhou University. After completing the examination, the tongue mass was surgically removed. After a follow-up of 11 months, the patient's condition was satisfactory and no temporary discomfort was observed. The case of tongue mass secondary to SJS is extremely rare. If a stomatologist encounters a similar case, we should carefully inquire about the drug allergy history and recent medication history, and be alert to whether or not they had adverse drug reactions recently.


Asunto(s)
Masculino , Humanos , Síndrome de Stevens-Johnson/tratamiento farmacológico , Hiperplasia/patología , Piel , Hipersensibilidad a las Drogas/patología , Lengua
2.
An. bras. dermatol ; 87(3): 375-381, May-June 2012. ilus, tab
Artículo en Inglés | LILACS | ID: lil-638525

RESUMEN

BACKGROUND: Few studies have evaluated the ultrastructure of the superficial skin nerves in urticaria. OBJECTIVE: The objective of this study was to describe findings in superficial skin nerves in cases of drug-induced acute urticaria. METHODS: Seven patients with drug-induced acute urticaria were included in the study. Skin biopsies were obtained from the urticarial lesion and from the apparently normal skin. The 14 fragments collected were processed for immunogold electron microscopy using single stains for antitryptase and anti-FXIIIa antibodies, as well as double immunogold labeling for both. RESULTS: Some sections showed mast cells in the process of degranulation. Following double immunogold staining, 10 nm (FXIIIa) and 15 nm (Tryptase) gold particles were found together throughout the granules in mast cells, indicating that tryptase and FXIIIa are located inside each one of the granules of these cells. Interestingly, we found strong evidence of the presence of tryptase and factor XIIIa in the superficial skin nerves of these patients, both in cases of urticarial lesions (wheals) and in the apparently normal skin. CONCLUSIONS: Tryptase and FXIIIa are present in the superficial nerves of the skin in drug-induced acute urticaria. This is the first report of tryptase and FXIIIa expression in the superficial skin nerves of patients with urticaria. Tryptase may be participating in neural activation in these patients, while FXIIIa may be present in the nerves to guarantee the functional integrity of structures.


FUNDAMENTOS: Poucos autores têm estudado a ultraestrutura dos nervos superficiais na urticária. OBJETIVO: Descrever os achados nos nervos cutâneos superficiais em casos de urticária aguda induzida por medicamentos. MÉTODOS: Sete pacientes com urticária aguda induzida por medicamentos foram incluídos no estudo. Foram obtidas biopsias da pele da lesão urticariforme e da pele aparentemente normal. Os 14 fragmentos coletados foram processados usando imunomarcação com ouro para anticorpos anti-triptase e anti-FXIIIa separadamente, além da dupla imunomarcação com ambos anticorpos. A seguir as amostras foram submetidas à análise por microscopia imunoeletrônica. RESULTADOS: Alguns cortes demonstraram mastócitos em processo de degranulação. Após a imunomarcação dupla, partículas de ouro de 10 nm (FXIIIa) e partículas de ouro de 15 nm (Triptase) apresentavam-se juntas em grânulos de mastócitos indicando que a triptase e o FXIIIa se localizam dentro de cada um dos grânulos dessas células. Curiosamente, foi encontrada uma forte evidência da presença da triptase e do fator XIIIa nos nervos superficiais dos pacientes avaliados, tanto em lesões urticadas, como na pele aparentemente normal. CONCLUSÕES: A triptase e o FXIIIa estão presentes nos nervos superficiais da pele na urticária aguda medicamentosa. Este é o primeiro relato da expressão de triptase e de FXIIIa nos nervos superficiais na urticária. A triptase poderia estar participando da ativação neural nos pacientes estudados. O FXIIIa poderia estar presente nos nervos, com a finalidade de manter a integridade funcional dessas estruturas.


Asunto(s)
Adulto , Femenino , Humanos , Persona de Mediana Edad , Hipersensibilidad a las Drogas/patología , Piel/inervación , Urticaria/patología , Hipersensibilidad a las Drogas/inmunología , Factor XIIIa/metabolismo , Inmunohistoquímica , Microscopía Inmunoelectrónica , Nervios Periféricos/ultraestructura , Piel/enzimología , Triptasas/metabolismo , Urticaria/inducido químicamente , Urticaria/inmunología
3.
Journal of Forensic Medicine ; (6): 125-128, 2011.
Artículo en Chino | WPRIM | ID: wpr-983638

RESUMEN

OBJECTIVE@#To explore the characteristics of autopsy cases of anaphylactic shock induced by cephalosporins and provide the evidences in forensic medicine.@*METHODS@#Twenty cases of anaphylactic shock induced by cephalosporins were collected from April 2005 to August 2009 in judicial expertise center of China Medical University, and the characteristics of the cases were analyzed retrospectively.@*RESULTS@#The age of decedents ranged from 40 to 60 years. Ninety percent of cases were from local medical centers and private clinics. The symptoms of the shock appeared 30 s-150 min after the administration of the drug, and death occurred 10 min-210 min after the appearance of the shock symptoms. In all cases, various degrees of eosinophil infiltration were observed in trachea and the lungs. Serum IgE detected by ELISA method was normal value in 14 cases.@*CONCLUSION@#In fatal anaphylactic cases, little specific findings are detected during postmortem and microscope examination. For this reason, the determination of cause of death in these cases requires comprehensive analysis combined with clinic information and excludes other diseases leading to the sudden death.


Asunto(s)
Adolescente , Adulto , Niño , Preescolar , Femenino , Humanos , Lactante , Masculino , Persona de Mediana Edad , Adulto Joven , Anafilaxia/patología , Antibacterianos/efectos adversos , Autopsia , Causas de Muerte , Cefalosporinas/efectos adversos , Hipersensibilidad a las Drogas/patología , Edema/patología , Patologia Forense , Inmunoglobulina E/sangre , Infusiones Intravenosas , Laringe/patología , Pulmón/patología , Estudios Retrospectivos , Tráquea/patología
4.
Arch. argent. pediatr ; 95(2): 101-6, abr. 1997. ilus
Artículo en Español | LILACS | ID: lil-217082

RESUMEN

Comunicamos el caso de un varón de 12 años con un cuadro clínico compatible con hipersensibilidad a la carbamazepina, después de 29 días de tratamiento con ese fármaco. Inicialmente se lo confundió con enfermedad de Kawasaki: fue tratado, sin respuesta, con gammaglobulina endovenosa y ácido acetilsalicílico. La sustitución de la carbamazepina y la corticoterapia resolvieron el cuadro. Se llevó a cabo una revisión bibliográfica para analizar los diferentes signos y síntomas que pueden manifestarse, los diagnósticos diferenciales, las posibles pruebas diagnósticas y las modalidades terapéuticas


Asunto(s)
Humanos , Masculino , Niño , Carbamazepina/efectos adversos , Hipersensibilidad a las Drogas/diagnóstico , Diagnóstico Diferencial , Erupciones por Medicamentos/etiología , Erupciones por Medicamentos/patología , Hipersensibilidad a las Drogas/complicaciones , Hipersensibilidad a las Drogas/patología , Prednisona , Prednisona/uso terapéutico
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA